MARKET

IQV

IQV

Iqvia Hldgs Inc
NYSE
227.10
-0.15
-0.07%
Opening 15:46 04/18 EDT
OPEN
225.19
PREV CLOSE
227.25
HIGH
230.48
LOW
222.71
VOLUME
385.63K
TURNOVER
0
52 WEEK HIGH
261.73
52 WEEK LOW
167.42
MARKET CAP
41.34B
P/E (TTM)
31.16
1D
5D
1M
3M
1Y
5Y
Bank of America Securities Reaffirms Their Buy Rating on IQVIA Holdings (IQV)
TipRanks · 1d ago
Press Release: IQVIA to Announce First-Quarter 2024 Results on May 2, 2024
IQVIA to announce its first-quarter 2024 financial results on May 2, 2024. The company will also host a conference call and webcast at 9:00 a.m. Eastern Time. IQVIA is a leading provider of advanced analytics, technology solutions to the life sciences industry.
Dow Jones · 3d ago
Weekly Report: what happened at IQV last week (0408-0412)?
Weekly Report · 3d ago
AbbVie keeps Humira market share near 100% despite biosimilars: report
Healthcare AbbVie keeps Humira market share near 100% despite biosimilars: report. Humira is the world's bestselling drug for the 10th year in a row. Amgen launched the first biosimilar version of the arthritis drug in the U.S. Last year.
Seeking Alpha · 5d ago
IQVIA HOLDINGS INC <IQV.N>: MIZUHO RAISES TARGET PRICE TO $277 FROM $268
Reuters · 04/11 11:46
Is IQVIA Holdings (NYSE:IQV) Using Too Much Debt?
IQVIA Holdings Inc. Carries debt of US$13.7b. The company's balance sheet shows that it is in a good position to manage its debt levels. IQVIA has a debt to EBITDA ratio of 4.5 and its free cash flow is higher than its debt. The balance sheet is a good place to look at to assess a company's ability to manage debt. IQvIA Holdings grew its EBIT at 11% over the last 12 months. The stock has a warning sign of 2 warning signs for companies with heavy debt.
Simply Wall St · 04/11 11:02
U.S. RESEARCH ROUNDUP-Airbnb, Albemarle, Biogen
Wall Street analysts revise their ratings and price targets on several U.S.-listed companies. Airbnb, Albemarle and Biogen among those with revised targets. AIG, Aflac and Allstate among companies with new targets for the day. Analysts cut target prices on some of the companies.
Reuters · 04/11 07:32
Global Stock leaders for 2030 in Health Tech - UBS
UBS highlights companies in the greentech, enabling tech, fintech, and healthtech sectors. The need for waste reduction and efficiency could be catalysts for rising healthcare spending. When it comes to healthtech, spending as a percentage of global GDP is almost 11%. UBS lists these global stocks as leaders in the healthtech space.
Seeking Alpha · 04/10 17:49
More
About IQV
IQVIA Holdings Inc. is a global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. The Company's Connected Intelligence delivers insights enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients. The Company operates through three segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real-world insights and services to life science clients. Research & Development Solutions primarily serves biopharmaceutical clients, provides outsourced clinical research and clinical trial services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market.

Webull offers Iqvia Holdings Inc stock information, including NYSE: IQV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IQV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IQV stock methods without spending real money on the virtual paper trading platform.